Videos

Sprint Biosciences CEO Johan Emilsson participated in the Global Forum, organized by BioStock, in Lund on May 21. Watch the recording of the presentation with subsequent Q&A session.

Sprint Biosciences CEO Johan Emilsson was interviewed by Redeye in connection with the company's interim report for the first quarter of 2026. See the interview here:

Sprint Biosciences' CEO, Johan Emilsson, presented the company and its operations at an investor meeting organized by Aktieinfo.net in Aarhus, Denmark, on April 22. See the presentation and the subsequent Q&A session here:

Johan Emilsson participated in Financial Stockholm's investor meeting held at the Sheraton Stockholm Hotel, on March 26, 2026. See the presentation and the subsequent Q&A session here:

Johan Emilsson participated on March 25, 2026, at Økonomisk Ugebrev's investor meeting in Copenhagen, Denmark. See the presentation and the subsequent Q&A session here:

Sprint Biosciences CEO Johan Emilsson was interviewed by Redeye in connection with the publication of the year-end report 2025. See the interview here:

In an interview with BioStock, CEO Johan Emilsson reports directly from J.P. Morgan Healthcare Week, which was held on January 12-15 in San Francisco, USA. J.P. Morgan Healthcare Week is usually seen as the most important meeting place of the year for the global life science industry. It brings together leading players for a week of partnering, investor meetings and groundbreaking ideas. See...

At Redeye's Life Science Day on December 3, Sprint Biosciences CEO Johan Emilsson and CSO Martin Andersson gave a short presentation followed by a live Q&A with Redeye analysts. Watch the recording here.

Sprint Biosciences CEO Johan Emilsson was interviewed by Redeye in connection with the publication of the interim report for the second quarter of 2025. See the interview here:

Sprint Biosciences CEO Johan Emilsson participated in the BioStock Life Science Summit in Lund on November 12. Watch the recording of the presentation with subsequent Q&A session.

Sprint Biosciences CEO Johan Emilsson was interviewed by Redeye in connection with the publication of the interim report for the second quarter of 2025. See the interview here:

Sprint Biosciences CEO Johan Emilsson was interviewed by Redeye in connection with the release of the company's interim report for the first quarter of 2024. See the interview here.